INNOTEST® β-AMYLOID(1-40) (96T)

Looking for additional resources?

Create your free e-services account and get access.
  • Find & download CoA, SDS and CE declarations of conformity
  • Unlimited acces to our free e-learning videos
  • See all event dates where our products are presented

The INNOTEST® β-AMYLOID(1-40) is a solid-phase enzyme immunoassay for the quantitative determination of β-amyloid(1-40) in human cerebrospinal fluid (CSF)1,2 in the clinical setting of dementia diagnosis. Values for the 40- and 42-AA-long β-amyloid peptides can be expressed as a β-amyloid ratio, which is of particular use in patients in which an indeterminate CSF biomarker profile (based on 42-AA-long β-amyloid, TAU and Phospho-TAU) is observed1,2.

Article no. 80462 (96T – CE) - Please contact your local Fujirebio representative for the availability of this product in your country.

 

Features & Benefits

  • User-friendly enzyme  immunoassay, standard technology
  • Generic and color-coded components
  • Ready-to-use Calibrators reduce inter and intra run variation
  • Run Validation Controls for assay run validation
  • Sample dilution: 1:100 for CSF samples
  • Sample volume: 75 µL diluted sample. Duplicate testing is strongly recommended and requires 2 x 75 µL diluted sample.
  • Calibrator range: 7,8 to 1000 pg/mL
  • This assay should be used in combination with the (1-40) CAL-RVC pack, article no. 81586 (RUO) and 80461 (CE).

* For research use only. Not for use in diagnostic procedures.

 

References

  1. Dumurgier et al. Cerebrospinal fluid amyloid-ß 42/40 ratio in clinical setting of memory centers: a multicentric study. Alzheimers Res Ther. 2015; 7(1):30. doi: 10.1186/s13195-015-0114-5.

  2. Slaets et al. Cerebrospinal fluid Aβ1-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels. J Alzheimers Dis. 2013; 36(4): 759-67.

 

Disclaimer

A license for the use of amyloid beta monoclonal antibodies contained in this product under patents US 6114133, US 7811769, and EP 0792458 has been obtained from Eli Lilly and Company.

Additional resources:

These resources are either available in free access or for users holding a Premium eServices account:

CLOSE

You can change the country filter for contents in our website. You will then see local contact information and other information available for that country. Please choose your country in the list below:

Looking for additional resources?

Create your free eServices account and get access to all our extra documentation (certificates, data sheets, ...), event dates where our products are presented, FAQs, ...

  • Find & download CoA, SDS and CE declarations of conformity
  • Unlimited access to our free eLearning videos
  • See all event dates where our products are presented

Already have an account? Log in here

Welcome to Fujirebio

It looks as if you are visiting from the United States. The content of this website is not destined for United States visitors.

If you continue your visit you confirm that you understand that not all of the products you will see listed are FDA cleared. FDA cleared products may not be cleared for all indications mentioned on this site. Product claims may differ from country to country based on regulations and approvals.

Please contact your country representative for further details.

Looking for additional resources?

Create your free e-services account and get access.
  • Find & download CoA, SDS and CE declarations of conformity
  • Unlimited acces to our free e-learning videos
  • See all event dates where our products are presented

Quick access